verbio Vereinigte BioEnergie (VBK) AI Stock Analysis

• Market Cap: €821.93M
• Dividend Yield: 1.55%
• Average Volume (3M): 152.63K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.20
• Revenue Growth: -4.72%
• EPS Growth: -789.75%
• Country: DE
• Employees: 1,521
• Sector: Energy
• Sector Strength: 52
• Industry: Chemicals - Specialty
• EPS (TTM): -1.52
• Shares Outstanding: 63,715,480
• 10 Day Avg. Volume: 199,760
• 30 Day Avg. Volume: 152,630
• PEG Ratio: <0.01
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.49
• P/FCF Ratio: -6.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €12.40
• Price Target Upside: -3.88% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 57 Neutral
• Price Target: €14.00 ▲(8.53% Upside)

The overall stock score is primarily influenced by significant financial challenges, including declining profitability and cash flow issues. Despite strong technical indicators suggesting bullish momentum, the negative P/E ratio and low dividend yield indicate valuation concerns. The earnings call provided some optimism for future regulatory support, but current financial struggles remain a substantial risk.

Positive Factors

Regulatory Environment

The introduction of stricter biofuel regulations in Germany could create a more favorable market environment, supporting Verbio's strategic focus on sustainability and potentially boosting demand for its biofuel products.

Strategic Expansion

Enhanced plant utilization in North America, especially in the biodiesel sector, indicates successful strategic expansion efforts, which could lead to sustained EBITDA growth and increased market share in the region.

Production Capacity

High production capacity and utilization rates demonstrate operational efficiency and the ability to meet demand, supporting revenue stability and growth in the bioenergy sector.

Negative Factors

Declining Profitability

The sharp decline in gross profit margin reflects operational challenges and cost pressures, which could hinder long-term profitability and financial health if not addressed effectively.

Cash Flow Issues

Negative free cash flow indicates struggles in cash generation, potentially limiting the company's ability to invest in growth opportunities and maintain financial flexibility.

EBITDA Decline

The significant decline in EBITDA highlights market challenges and operational inefficiencies, which could impact the company's ability to sustain growth and profitability in the competitive bioenergy sector.

verbio Vereinigte BioEnergie Business Overview & Revenue Model

Company Description

VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.

How the Company Makes Money

Verbio makes money primarily through the production and sale of biofuels such as biodiesel and bioethanol, which are distributed to energy companies and fuel distributors. Another significant revenue stream is the production of biomethane, which is injected into the natural gas grid and sold to both industrial and individual customers. The company also generates income from the sale of by-products, such as biofertilizers, which are derived from the production process and sold to the agricultural sector. Additionally, Verbio benefits from partnerships and collaborations with agricultural producers and energy companies, which help in securing raw materials and expanding its market reach.

verbio Vereinigte BioEnergie Financial Statement Overview

Summary

The company is experiencing declining revenues and profitability, with a negative net profit margin and increased debt. The cash flow has worsened significantly, which is concerning for liquidity.

Income Statement

The income statement reveals some troubling trends. Revenue has declined significantly from 2023 to TTM 2025, with a notable drop in net income, resulting in a negative net profit margin of -2.16% for TTM. The gross profit margin also decreased compared to previous years, indicating declining profitability. However, the company maintained a gross profit margin of 17.06% and an EBITDA margin of 4.27% in the TTM, showing some operational efficiency.

Balance Sheet

The balance sheet displays a stable equity position with an equity ratio of 62.88% for TTM, indicating good financial stability. The debt-to-equity ratio has increased to 0.30 in the TTM period, showing a higher reliance on debt compared to previous years. Despite this, the company's return on equity has turned negative due to the net loss, which is a concern for investors. Overall, the financial position is stable but shows signs of strain.

Cash Flow

Cash flow analysis highlights some risks, with a negative free cash flow in TTM of -95.18 million, worsening from previous periods. The operating cash flow to net income ratio is positive at 1.13, indicating operational cash generation despite the net loss. However, the negative free cash flow and its deterioration are concerning for future liquidity and investment capacity.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.58B	1.58B	1.67B	1.97B	1.81B	1.03B
Gross Profit	102.56M	37.12M	292.45M	381.91M	626.92M	271.64M
EBITDA	15.40M	-54.40M	122.92M	242.68M	494.81M	166.48M
Net Income	-138.01M	-138.01M	19.96M	132.02M	315.63M	93.20M
Balance Sheet
Total Assets	1.30B	1.30B	1.38B	1.30B	1.13B	678.62M
Cash, Cash Equivalents and Short-Term Investments	64.41M	64.41M	126.70M	170.31M	300.50M	105.34M
Total Debt	268.86M	268.86M	194.20M	189.97M	49.39M	46.48M
Total Liabilities	527.61M	527.61M	449.54M	385.36M	310.16M	168.75M
Stockholders Equity	746.29M	746.29M	925.67M	909.47M	816.23M	507.85M
Cash Flow
Free Cash Flow	-118.66M	-117.96M	-54.38M	-177.12M	210.15M	49.90M
Operating Cash Flow	13.88M	13.88M	116.78M	26.09M	325.03M	117.18M
Investing Cash Flow	-120.06M	-120.06M	-144.90M	-266.43M	-113.62M	-46.56M
Financing Cash Flow	49.88M	49.88M	-19.53M	112.21M	-18.48M	-18.76M

verbio Vereinigte BioEnergie Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 12.90
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Positive. The current price of 12.9 is above the 20-day moving average (MA) of 11.43, above the 50-day MA of 10.80, and above the 200-day MA of 10.33, indicating a bullish trend. The MACD of 0.55 indicates Negative momentum. The RSI at 66.21 is Neutral, neither overbought nor oversold. The STOCH value of 86.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:VBK.

verbio Vereinigte BioEnergie Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACT	74 Outperform	€1.59B	27.41	29.12%	1.15%	1.03%	25.48%
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
EVK	64 Neutral	€6.69B	15.77	4.87%	8.15%	-2.62%	―
VBK	57 Neutral	€821.93M	―	-16.51%	1.55%	-4.72%	-789.75%
WCH	51 Neutral	$3.19B	13.25	5.37%	3.89%	-10.63%	-23.15%
1COV	50 Neutral	€10.99B	―	-5.90%	―	-1.98%	-16.31%
LXS	46 Neutral	$1.72B	―	-3.72%	0.50%	-2.75%	83.47%